[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367012-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367012-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","association-of-urinary-cadmium-and-arsenic-with-gynecological-cancers-results-from-nhanes-20032018","Association of urinary cadmium and arsenic with gynecological cancers - Results from NHANES 2003—2018","","Objective: Previous studies indicate that cadmium and arsenic may exert estrogen-like effects and influence gynecologic tumor development. This study examines the association between urinary cadmium/arsenic levels and the prevalence of gynecologic cancers using NHANES data from 2003 to 2018. Methods: Female participants were analyzed with dataset merging in R, strict exclusions, and binary logistic regression; propensity score matching was applied for robustness. Results: Higher urinary cadmium and arsenic were risk factors overall, with cadmium remaining significant after PSM and both metals associated with ovarian cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-of-urinary-cadmium-and-arsenic-with-gynecological-cancers-results-from-nhanes-20032018/367012/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-of-urinary-cadmium-and-arsenic-with-gynecological-cancers-results-from-nhanes-20032018/367012.png","ImageObject",300,407,{"name":42,"@type":43},"moss~","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of analyzing urinary cadmium and arsenic levels in relation to gynecologic cancers?","Question",{"text":63,"@type":64},"The study aims to explore whether urinary cadmium and arsenic levels are associated with the prevalence of gynecologic cancers, based on evidence of estrogen-like effects of these metals.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were associations tested in the study?",{"text":68,"@type":64},"Female participants from NHANES 2003—2018 were analyzed, and binary logistic regression models assessed associations between urinary cadmium/arsenic and gynecologic cancer risk, with propensity score matching used for robustness.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancers showed significant associations with urinary cadmium and arsenic?",{"text":72,"@type":64},"Cadmium and arsenic were risk factors for gynecologic cancers overall; subgroup analyses indicated risk for ovarian cancer for both metals, and cadmium increased endometrial cancer risk.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367012,1790219642,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","DOI：10 . 11817/j.issn.1672-7347.2025.240591  \nAssociation of urinary cadmium and arsenic with gynecological cancers: Results from NHANES 2003—2018  \nJIANG Yuanna1, 2, WANG Jie2, 3, HE Zhouxiao1, XIANG Xuanang1, YANG Ruichen1, WANG Qian1, CAO Lanqin1  \n[1. Department of Obstetrics and Gynecology, Xiangya Hospital, Central South University, Changsha 410008;  \n2. National Health Commission Key Laboratory of Cancer Proteomics (Xiangya Hospital, Central South University), Changsha 410008; 3. Department of Gastroenterology, Xiangya Hospital, Central South University,  \nChangsha 410008, China]  \nABSTRACT Objective: Previous studies have demonstrated that the metals cadmium and arsenic  \nexhibit estrogen-like effects and may influence the occurrence and development of gynecological tumors. This study aims to explore the association between urinary cadmium and arsenic levels and the prevalence of gynecologic cancers using data from the National Health and Nutrition Examination Survey (NHANES) .  \nMethods: Data from female participants in NHANES 2003—2018 were analyzed. Using R software, datasets (DEMO, BMX, etc.) were merged, and complete cases were retained by intersecting row names, yielding a total of 2 999 participants. After applying strict exclusion criteria, 2 802 participants were included: 83 with gynecologic cancer (cancer group) and 2 719 without (control group) . Demographic, reproductive health, and urinary cadmium and arsenic data were collected. Binary Logistic regression models were employed to assess associations between urinary cadmium and arsenic levels and gynecologic cancer risk.  \nResults: High urinary cadmium and arsenic levels were risk factors for gynecologic cancers, with odds ratios (ORs) of 1.623 (95% CI 1.217 to 2 . 166) and 1.003 (95% CI 1.001 to 1.005), respectively. After propensity score matching (PSM), the trend remained; cadmium was still a statistically significant risk factor with an OR of 2.182 (95% CI 1.343 to 3.545), while arsenic ’ s association, though not statistically significant, still trended toward risk (OR=1 .004, 95% CI 0.999 to 1.009) . Subgroup analyses showed that both cadmium and arsenic were risk factors for ovarian cancer (OR=1 .745, 95% CI 1.178 to 2.586 and OR=1 .005, 95% CI 1.002 to 1.008, respectively); these associations persisted  \nDate of reception: 2024-10-31  \nFirst author: JIANG Yuanna, Email: [228111119@csu.edu.cn](228111119@csu.edu.cn), ORCID: 0009-0001-5145-0453  \nCorresponding author: CAO Lanqin, Professor, Email: [401531@csu.edu.cn](401531@csu.edu.cn), ORCID: 0000-0002-8235-8713  \nFoundation item: This work was supported by the Science and Technology Innovation Program of Hunan Province, China (2020SK2073) .  \nOpen access: This is an open access article under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND  \n4.0) ([https://creativecommons.org/licenses/by-nc-nd/4.0/](https://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n©Journal of Central South University (Medical Science) . All rights reserved.  \nafter PSM. Additionally, cadmium increased the risk of endometrial cancer (OR=1 .617, 95% CI 1. 109 to 2 .356) .  \nConclusion: Exposure to cadmium and arsenic is associated with an increased risk of ovarian and endometrial cancers. These findings suggest that reducing environmental exposure to heavy metals such as cadmium and arsenic may help prevent certain gynecologic cancers.  \nKEY WORDS gynecologic cancer; urinary cadmium; urinary arsenic; ovarian cancer; endometrial cancer  \n尿镉和砷与妇科癌症的相关性：  \n基于NHANES 2003—2018数据分析  \n姜元娜1, 2，王婕2, 3，何周晓1，向轩昂1，杨瑞琛1，王前1，曹兰琴1  \n(1 .中南大学湘雅医院妇产科，长沙410008； 2.国家卫健委肿瘤蛋白质组学重点实验室，长沙410008；  \n3.中南大学湘雅医院消化内科，长沙410008)  \n[摘要] 目的：既往研究表明，金属镉、砷具有雌激素效应，对妇科肿瘤的发生、发展具有一定影响。本研究通过分析美国国家健康与营养调查(National Health and Nutrition Examination Survey，NHANES)的数据，探讨尿液中镉和砷水平与妇科恶性肿瘤发病率之间的关系。 方法：利用NHANES 2003至2018年期间的数据，以女性参与者为研究人群，通过R语言合并数据集(DEMO、 BMX等指标)，按行名取交集保留完整数据，最终纳入2 999例。根据严格的排除指标，锁定2 802例为研究对象，其中将83例妇科癌症患者作为肿瘤组，将2 719例未患妇","cbCaiqlOJRAyyfVI","https://ap.wps.com/l/cbCaiqlOJRAyyfVI","pdf",1087819,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Keywords","[{\"question\":\"What is the purpose of analyzing urinary cadmium and arsenic levels in relation to gynecologic cancers?\",\"answer\":\"The study aims to explore whether urinary cadmium and arsenic levels are associated with the prevalence of gynecologic cancers, based on evidence of estrogen-like effects of these metals.\"},{\"question\":\"How were associations tested in the study?\",\"answer\":\"Female participants from NHANES 2003—2018 were analyzed, and binary logistic regression models assessed associations between urinary cadmium/arsenic and gynecologic cancer risk, with propensity score matching used for robustness.\"},{\"question\":\"Which cancers showed significant associations with urinary cadmium and arsenic?\",\"answer\":\"Cadmium and arsenic were risk factors for gynecologic cancers overall; subgroup analyses indicated risk for ovarian cancer for both metals, and cadmium increased endometrial cancer risk.\"}]","Association of urinary cadmium and arsenic with gynecological cancers - Results from NHANES 2003—2018 | PDF",1790168825,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/087bdbf5460a84753d6d31db012609e5.webp",983,1378,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08cf6a02609b95ca7c2ebed06ae93abc.webp",982,1377,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7e6daf971d50ed8f9d40d50e727ab0f.webp",981,1375,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9487b54d251668973846fe20efac3589.webp",980,1374]